ZUVCHEM continues to strengthen its nationwide pharmaceutical distribution capabilities with a growing portfolio of active state licenses, renewals, and advanced-stage regulatory applications across the United States. These approvals support ZUVCHEM’s expanding distribution of pharmaceutical‑grade APIs and reinforce the company’s commitment to regulatory compliance and supply‑chain integrity.
Active & Newly Renewed Licenses: ZUVCHEM now holds valid Board of Pharmacy or Department of Health registrations in several key states, including:
ZUVCHEM’s approvals authorize the compliant wholesale distribution of cGMP‑produced APIs and related pharmaceutical ingredients to human and veterinary compounding pharmacy clients throughout all licensed jurisdictions.
Advanced‑Stage Applications in Progress: ZUVCHEM is advancing several additional state applications now in late‑stage or final review. Follow our updates as we continue expanding our national licensing coverage
Recent articles
ZUVCHEM Announces 2026 Industry Event Attendance Plans
As part of its continued engagement with the global pharmaceutical, nutraceutical, and fine‑chemical sectors, ZUVCHEM is preparing to participate in several key industry events throughout 2026. These meetings provide an opportunity to…
Read More
ZUVCHEM Expands U.S. Licensing Footprint Across Multiple State Boards of Pharmacy
ZUVCHEM continues to strengthen its nationwide pharmaceutical distribution capabilities with a growing portfolio of active state licenses, renewals, and advanced-stage regulatory applications across the United States. These approvals support ZUVCHEM’s expanding…
Read More
ZUVCHEM Launches U.S. Distribution of Cholecalciferol (Vitamin D3) 40 MIU/g API
ZUVCHEM announces the availability of Pharmaceutical‑Grade Cholecalciferol (Vitamin D3) 40,000,000 IU/g powder for prescription compounding use. The API is manufactured by Taizhou Hisound Pharmaceutical Co., Ltd. Labeled and distributed by ZUVCHEM across multiple…
Read More